Agonist-Like or Antagonist-Like Treatment for Cocaine Dependence with Methadone for Heroin Dependence: Two Double-Blind Randomized Clinical Trials (original) (raw)
Ball JC, Corty E (1988). Basic issues pertaining to the effectiveness of methadone maintenance treatment. NIDA Res Monogr86: 178–191. CASPubMed Google Scholar
Bano MD, Mico JA, Aguietas M, Lopez ML, Guillen JL (2001). Olanzapine efficacy in the treatment of cocaine abuse in methadone maintenance patients. Interactions and plasma levels (abstract English). Actas Esp Psiquiatria29: 215–220. CAS Google Scholar
Beck AT, Steer RA, Brown GK (1996). Beck Depression Inventory, 2nd edn. The Psychological Corporation: San Antonio, TX. Google Scholar
Bourke DL, Allen PD, Rosenberg M, Mendes RW, Karabelas AN (1983). Dextroamphetamine with morphine: respiratory effects. J Clin Pharmacol23: 65–70. ArticleCAS Google Scholar
Charnaud B, Griffiths V (1998). Levels of intravenous drug misuse among clients prescribed oral dexamphetamine or oral methadone: a comparison. Drug Alcohol Depend52: 79–84. ArticleCAS Google Scholar
Cohen J (1988). Statistical Power Analysis for the Behavioral Sciences, 2nd edn Lawrence Erlbaum Associates: Hillsdale, NJ. Google Scholar
First M, Spitzer R, Gibbon M, Williams J (1995). Structured Clinical Interview for DSM-IV Axis I Disorders–Patient Edition. New York State Psychiatric Institute: New York. Google Scholar
Foltin RW, Fischman MW (1992). The cardiovascular and subjective effects of intravenous cocaine and morphine combinations in humans. J Pharmacol Exp Therapeut261: 623–632. CAS Google Scholar
Foltin RW, Fischman MW (1996). Effects of methadone or buprenorphine maintenance on the subjective and reinforcing effects of intravenous cocaine in humans. J Pharmacol Exp Therapeut278: 1153–1164. CAS Google Scholar
Foltin RW, Fischman MW (1998). Effects of ‘binge’ use of intravenous cocaine in methadone-maintained individuals. Addiction93: 825–836. ArticleCAS Google Scholar
Forrest Jr WH, Brown Jr BW, Brown CR, Defalque R, Gold M, Gordon HE et al (1977). Dextroamphetamine with morphine for the treatment of postoperative pain. N Engl J Med296: 712–715. Article Google Scholar
Goodman L, Gilman A (1941). The Pharmacological Basis of Therapeutics. The Macmillan Co.: NY. Google Scholar
Grabowski J, O’Brien CP, Greenstein R, Ternes J, Long M, Steinberg-Donato S (1979). Effects of contingent payment on compliance with a naltrexone regimen. Am J Drug Alcohol Abuse6: 355–365. ArticleCAS Google Scholar
Grabowski J, Rhoades H, Elk R, Schmitz J, Creson D (1993). Methadone dosage, cocaine and opiate abuse [letter]. Am J Psychiatry150: 675. CASPubMed Google Scholar
Grabowski J, Rhoades H, Elk R, Schmitz J, Davis C, Creson D et al (1995). Fluoxetine is ineffective for treatment of cocaine dependence or concurrent opiate and cocaine dependence: two placebo-controlled double-blind trials. J Clin Psychopharmacol15: 163–174. ArticleCAS Google Scholar
Grabowski J, Rhoades H, Schmitz J, Stotts A, Daruzska LA, Creson D et al (2001). Dextroamphetamine for cocaine-dependence treatment: a double-blind randomized clinical trial. J Clin Psychopharmacol21: 522–526; (Also summarized and reviewed in Evidence Based Medicine: Mental Health, 2002). ArticleCAS Google Scholar
Grabowski J, Rhoades H, Silverman P, Schmitz JM, Stotts A, Creson D et al (2000a). Risperidone for the treatment of cocaine dependence: randomized, double-blind trial. J Clin Psychopharmacol20: 305–310. ArticleCAS Google Scholar
Grabowski J, Rhoades H, Stotts A, Schmitz J, Creson D, Moeller G et al (2000b). D-amphetamine for treatment of cocaine dependence: randomized double blind placebo controlled trials. Drug Alcohol Depend (Abstracts CPDD)60: 216. Google Scholar
Greenstein RA, O’Brien CP, McLellan AT, Woody GE, Grabowski J, Long M et al (1981). Naltrexone: a short-term treatment for opiate dependence. Am J Drug Alcohol Abuse8: 291–300. ArticleCAS Google Scholar
Griffiths RR, Brady JV, Bigelow GE (1981). Predicting the dependence liability of stimulant drugs. NIDA Res Monog37: 182–196; (Washington DC. DHHS (ADM) 81-1137). CAS Google Scholar
Gutierrez-Esteinou R, Grebb JA (1997). Risperidone: an analysis of the first three years in general use. Int Clin Psychopharmacol12 (Suppl 4): s3–s10. Article Google Scholar
Jasinski DR, Preston KL (1986). Evaluation of mixtures of morphine and d-amphetamine for subjective and physiological effects. Drug Alcohol Depend17: 1–13. ArticleCAS Google Scholar
Howell LL, Wilcox KM (2002). Functional imaging and neurochemical correlates of stimulant self-administration in primates. Psychopharmacology163: 352–361. ArticleCAS Google Scholar
Katz EC, Chutuape MA, Jones HE, Stitzer ML (2002). Voucher reinforcement for heroin and cocaine abstinence in an outpatient drug-free program. Exp Clin Psychopharmacol10: 136–143. Article Google Scholar
Klee H, Wright S, Carnwath T, Merrill J (2001). The role of substitute therapy in the treatment of problem amphetamine use. Drug Alcohol Rev20: 417–429. Article Google Scholar
Lamas X, Negus SS, Gatch MB, Mello NK (1998). Effects of heroin/cocaine combinations in rats trained to discriminate heroin or cocaine from saline. Pharmacol Biochem Behav60: 357–364. ArticleCAS Google Scholar
Laties VG, Weiss B (1967). Performance enhancement by the amphetamines: a new appraisal. In: Brill H et al (eds) Neuro-Psycho-Pharmacology. Excerpta Medica Foundation: Amsterdam. pp 800–808. Google Scholar
Laties VG, Weiss B (1981). The amphetamine margin in sports. Fed Proc40: 2689–2692. CASPubMed Google Scholar
Leri F, Bruneau J, Stewart J (2003). Understanding polydrug use: review of heroin and cocaine co-use. Addiction98: 7–22. Article Google Scholar
Levin FR, McDowell D, Evans SM, Brooks D, Spano C, Nunes EV (1999). Pergolide mesylate for cocaine abuse: a controlled preliminary trial. Am J Addict8: 120–127. ArticleCAS Google Scholar
Manzanedo C, Aguilar MA, Rodriguez-Arias M, Minarro J (2001). Effects of dopamine antagonists with different receptor blockade profiles on morphine-induced place preference in male mice. Behav Brain Res121: 189–197. ArticleCAS Google Scholar
Maxwell S, Shinderman MS (2002). Optimizing long term response to methadone maintenance treatment: a 152-week Follow-up using higher dose methadone. J Addict Dis21: 1–12. Article Google Scholar
McLellan AT, Kusher H, Metzger D, Peters R, Smith I, Grisson G et al (1992). The fifth edition of the Addiction Severity Index. J Substance Abuse Treat8: 199–213. Article Google Scholar
McManus MJ, Panzarella C (1986). The use of dextroamphetamine to counteract sedation for patients on a morphine drip. J Assoc Pediatr Oncol Nurses3: 28–29. ArticleCAS Google Scholar
Meil WM, Schecter MD (1997). Olanzapine attenuates the reinforcing effects of cocaine. Eur J Pharmacol340: 17–26. ArticleCAS Google Scholar
Mello NK, Negus SS (1996). Preclinical evaluation of pharmacotherapies for treatment of cocaine and opioid abuse using drug self-administration procedures. Neuropsychopharmacology14: 375–424. ArticleCAS Google Scholar
Mello NK, Negus SS (2001). Effects of indatraline and buprenorphine on self-administration of speedball combinations of cocaine and heroin by rhesus monkeys. Neuropsychopharmacology25: 104–117. ArticleCAS Google Scholar
Negus SS (2003). Rapid assessment of choice between cocaine and food in rhesus monkeys: effects of environmental manipulations and treatment with d-amphetamine and flupenthixol. Neuropsychopharmacology28: 919–931. Article Google Scholar
Negus SS, Gatch MB, Mello NK (1998). Discriminative stimulus effects of a cocaine/heroin ‘speedball’ combination in Rhesus monkeys. J Pharmacol Exp Therapeut285: 1123–1136. CAS Google Scholar
Negus SS, Mello NK (2003a). Effects of chronic d-amphetamine treatment on cocaine- and food-maintained responding under a progressive-ratio schedule in rhesus monkeys. Psychopharmacology167: 324–332. ArticleCAS Google Scholar
Negus SS, Mello NK (2003b). Effects of chronic d-amphetamine treatment on cocaine- and food-maintained responding under a second-order schedule in rhesus monkeys. Drug Alcohol Depend70: 39–52. ArticleCAS Google Scholar
Newton TF, Ling W, Kalechstein AD, Uslaner J, Tervo K (2001). Risperidone pre-treatment reduces the euphoric effects of experimentally administered cocaine. Psychiatry Res102: 227–233. ArticleCAS Google Scholar
Oliveto A, Kosten T, Schottenfeld R, Ziedonis D (1993). Cocaine abuse among methadone-maintained patients. Am J Psychiatry150: 1755. CASPubMed Google Scholar
Platt DM, Rowlett JK, Spealman RD (2002). Behavioral effects of cocaine and dopaminergic strategies for preclinical medication development. Psychopharmacology163: 265–282. ArticleCAS Google Scholar
Preston KL, Silverman K, Umbricht A, DeJesus A, Montoya ID, Schuster CR (1999). Improvement in naltrexone treatment compliance with contingency management. Drug Alcohol Depend54: 127–135. ArticleCAS Google Scholar
Rasmussen T, Sauerberg P, Nielsen EB, Swedberg MDB, Thomsen C, Sheardown MJ et al (2000). Muscarinic receptor agonists decrease cocaine self-administration rates in drug naïve mice. Eur J Pharmacol402: 241–246. ArticleCAS Google Scholar
Rhoades HM, Creson D, Elk R, Schmitz JM, Grabowski J (1998). Retention, HIV risk, and illicit drug use during treatment: methadone dose and visit frequency. Am J Public Health88: 34–39. ArticleCAS Google Scholar
Rothman RB, Blough BE, Baumann MH (2002). Appetite suppressants as agonist substitution therapies for stimulant dependence. Ann NY Acad Sci965: 109–126. ArticleCAS Google Scholar
Roy A, Roy M, Smelson DA (1998). Risperidone, ERG and cocaine craving [letter]. Am J Addict7: 90. ArticleCAS Google Scholar
Shearer J, Sherman J, Wodak A, Van Beek I (2002). Substitution therapy for amphetamine users. Drug Alcohol Rev21: 179–185. Article Google Scholar
Shearer J, Wodak A, van Beek I, Mattick RP, Lewis J (2003). Pilot randomized double blind placebo-controlled study of dexamphetamine for cocaine dependence. Addiction98: 1137–1141. Article Google Scholar
Shearer J, Wodak A, Mattick RP, van Beek I, Lewis J, Hall W et al (1999). A randomised controlled trial of feasibility of monitoring controlled prescribing of dexamphetamine. NDARC Technical Report, National Drug and Alcohol Research Centre, University of New South Wales, pp 1–43.
Shearer J, Wodak A, Mattick RP, Van Beek I, Lewis J, Hall W et al (2001). Pilot randomized controlled study of dexamphetamine substitution for amphetamine dependence. Addiction96: 1289–1296. ArticleCAS Google Scholar
Stine SM, Burns B, Kosten T (1991). Methadone dose for cocaine abuse. Am J Psychiatry148: 1268. CASPubMed Google Scholar
Strain EC, Bigelow GE, Liebson IA, Stitzer ML (1999). Moderate- vs high-dose methadone in the treatment of opioid dependence: a randomized trial [see comments]. J Am Med Assoc281: 1000–1005. ArticleCAS Google Scholar
Van Campenhout N, De Haes P, Meert TF (1999). Inability of antipsychotics to antagonize the cueing properties of cocaine in rats. Pharmacol Biochem Behav64: 435–438. ArticleCAS Google Scholar
Velasquez MM, Wright K, Ingersoll KS (2003). Treatment adherence and cardiovascular disease. In: Fowler G (ed). Twenty Common Problems in Cardiology. McGraw-Hill: New York. Google Scholar
Villano CL, Rosenblum A, Magura S, Fong C (2002). Improving treatment engagement and outcomes for cocaine-using methadone patients. Am J Drug Alcohol Abuse28: 213–230. Article Google Scholar
Wachtel SR, Ortengren A, de Wit H (2002). The effects of acute haloperidol or risperidone on subjective responses to methamphetamine in healthy volunteers. Drug Alcohol Depend68: 23–33. ArticleCAS Google Scholar
Weiss B, Laties VG (1962). Enhancement of human performance by caffeine and the amphetamines. Pharmacol Rev14: 1–36. CASPubMed Google Scholar
Weiss B, Laties VG (1970). Reconciling the effects of amphetamine on human and animal behavior. In: de C Baker SB (ed). The Correlation of Adverse Effects in Man with Observations in Animals. Excerpta Medica Foundation: Amsterdam. pp 32–36. Google Scholar
Wines JD, Weiss RD (1999). Opioid withdrawal during risperidone treatment. J Clin Psychopharmacol19: 265–266. Article Google Scholar